Eligibility Coronary Artery Disease NCT01655524

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who have had a qualifying regadenoson stress myocardial perfusion imaging (regadenoson nuclear stress test).
Descrizione

ID.1

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide an informed consent
Descrizione

ID.2

Tipo di dati

boolean

known allergic reaction to aminophylline or regadenoson
Descrizione

ID.3

Tipo di dati

boolean

systolic blood pressure < 90 mmhg
Descrizione

ID.4

Tipo di dati

boolean

unstable abnormal heart rhythm
Descrizione

ID.5

Tipo di dati

boolean

pulmonary edema
Descrizione

ID.6

Tipo di dati

boolean

acute coronary symptoms, myocardial infarction within 48 hours
Descrizione

ID.7

Tipo di dati

boolean

active dipyridamole, aminophylline or theophylline use
Descrizione

ID.8

Tipo di dati

boolean

pregnancy
Descrizione

ID.9

Tipo di dati

boolean

any contraindication to aminophylline according to the drug's package insert: uncontrolled seizure disorder, sepsis with multi-organ failure and liver impairment
Descrizione

ID.10

Tipo di dati

boolean

Similar models

Eligibility Coronary Artery Disease NCT01655524

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients who have had a qualifying regadenoson stress myocardial perfusion imaging (regadenoson nuclear stress test).
boolean
Item Group
C0680251 (UMLS CUI)
ID.2
Item
inability to provide an informed consent
boolean
ID.3
Item
known allergic reaction to aminophylline or regadenoson
boolean
ID.4
Item
systolic blood pressure < 90 mmhg
boolean
ID.5
Item
unstable abnormal heart rhythm
boolean
ID.6
Item
pulmonary edema
boolean
ID.7
Item
acute coronary symptoms, myocardial infarction within 48 hours
boolean
ID.8
Item
active dipyridamole, aminophylline or theophylline use
boolean
ID.9
Item
pregnancy
boolean
ID.10
Item
any contraindication to aminophylline according to the drug's package insert: uncontrolled seizure disorder, sepsis with multi-organ failure and liver impairment
boolean